1,734
Views
0
CrossRef citations to date
0
Altmetric
Research Article

MicroRNA-4521 targets hepatoma up-regulated protein (HURP) to inhibit the malignant progression of breast cancer

ORCID Icon, &
Article: 1996016 | Received 26 Aug 2021, Accepted 16 Oct 2021, Published online: 26 Oct 2021

References

  • Sang Y, Chen B, Song X, et al. circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer. Mol Ther. 2019;27(9):p. 1638–1652.
  • Winters S. Breast Cancer Epidemiology, Prevention, and Screening. Prog Mol Biol Transl Sci. 2017;151:p. 1–32.
  • Qiao K, Ning S, Wan L, et al. LINC00673 is activated by YY1 and promotes the proliferation of breast cancer cells via the miR-515-5p/MARK4/Hippo signaling pathway. J Exp Clin Cancer Res. 2019;38(1):p. 418.
  • Liang Y, Song X, Li Y, et al. LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis. Mol Cancer. 2020;19(1):p. 85.
  • Plantamura I, Cataldo A, Cosentino G, et al. miR-205 in Breast Cancer: state of the Art. Int J Mol Sci. 2020;22(1):27.
  • Feng X, Yan N, Sun W, et al. miR-4521-FAM129A axial regulation on ccRCC progression through TIMP-1/MMP2/MMP9 and MDM2/p53/Bcl2/Bax pathways. Cell Death Discov. 2019;5(1):p. 89.
  • Senfter D, Samadaei M, Mader RM, et al. High impact of miRNA-4521 on FOXM1 expression in medulloblastoma. Cell Death Dis. 2019;10(10):p. 696.
  • Kim E, Naisbitt S, Hsueh Y-P, et al. GKAP, a novel synaptic protein that interacts with the guanylate kinase-like domain of the PSD-95/SAP90 family of channel clustering molecules. J Cell Biol. 1997;136(3):p. 669–78.
  • Ke MJ, Ji LD, Li YX. Bioinformatics analysis combined with experiments to explore potential prognostic factors for pancreatic cancer. Cancer Cell Int. 2020;20:p. 382.
  • Zheng R, Shi Z, Li W, et al. Identification and prognostic value of DLGAP5 in endometrial cancer. PeerJ. 2020;8:p. e10433.
  • Weng Y, Liang W, Ji Y, et al. Key Genes and Prognostic Analysis in HER2+ Breast Cancer. Technol Cancer Res Treat. 2021;20:p. 1533033820983298.
  • Ganju A, Khan S, Hafeez BB, et al. miRNA nanotherapeutics for cancer. Drug Discov Today. 2017;22(2):p. 424–432.
  • Chi Y, Zhou D. MicroRNAs in colorectal carcinoma–from pathogenesis to therapy. J Exp Clin Cancer Res. 2016;35:p. 43.
  • Martinez-Gutierrez AD, Cantú de León D, Millan-Catalan O, et al. Identification of miRNA Master Regulators in Breast Cancer. Cells. 2020;9(7):1610.
  • Tang W, Zhang X, Tan W, et al. miR-145-5p Suppresses Breast Cancer Progression by Inhibiting SOX2. J Surg Res. 2019;236:p. 278–287.
  • Cai F, Chen L, Sun Y, et al. MiR-539 inhibits the malignant behavior of breast cancer cells by targeting SP1. Biochem Cell Biol. 2020;98(3):p. 426–433.
  • Menbari MN, Rahimi K, Ahmadi A, et al. MiR-216b-5p inhibits cell proliferation in human breast cancer by down-regulating HDAC8 expression. Life Sci. 2019;237:p. 116945.
  • Xing S, Tian Z, Zheng W, et al. Hypoxia downregulated miR-4521 suppresses gastric carcinoma progression through regulation of IGF2 and FOXM1. Mol Cancer. 2021;20(1):p. 9.
  • Branchi V, García SA, Radhakrishnan P, et al. Prognostic value of DLGAP5 in colorectal cancer. Int J Colorectal Dis. 2019;34(8):p. 1455–1465.
  • Shi YX, Yin J-Y, Shen Y, et al. Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer. Sci Rep. 2017;7(1):p. 8072.
  • Xu T. Elevated mRNA expression levels of DLGAP5 are associated with poor prognosis in breast cancer. Oncol Lett. 2020;19(6):p. 4053–4065.
  • Chen J, LIU Q-J, Wang DA, et al. Hepatoma upregulated protein expression is involved in the pathogenesis of human breast carcinogenesis. Oncol Lett. 2014;8(6):p. 2543–2548.